Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

ClinicalTrials.gov ID: NCT02973789

Public ClinicalTrials.gov record NCT02973789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, concurrent with standard therapies for stage 4 NSCLC patients, following progression while on or after platinum based treatment. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.

Study identification

NCT ID
NCT02973789
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NovoCure GmbH
Industry
Enrollment
291 participants

Conditions and interventions

Eligibility (public fields only)

Age range
22 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2016 (Type not available)
Primary completion
Sep 24, 2024 (Actual)
Completion
Oct 9, 2024 (Actual)
Last update posted
Mar 18, 2026

2016 – 2024

United States locations

U.S. sites
73
U.S. states
30
U.S. cities
62
Facility City State ZIP Site status
Central Alabama Research Birmingham Alabama 35209 —
Ironwood Cancer & Research Center Chandler Arizona 85224 —
Cancer Center at St. Joseph Hospital and Medical Center Phoenix Arizona 85004 —
Beverly Hills Cancer Center Beverly Hills California 90211 —
California Cancer Associates for Research and Excellence, Inc. cCARE Fresno California 93720 —
St. Joseph Heritage Healthcare Fullerton California 92835 —
Saddleback Memorial Medical Center Laguna Hills California 92653 —
Redlands Community Hospital (Emad Ibrahim, MD, Inc.) Redlands California 92373 —
Dignity Health - Mercy Cancer Centers Sacramento California 95186 —
Sutter Institute for Medical Research Sacramento California 95816 —
Innovative Clinical Research Institute Whittier California 90603 —
Banner MD Anderson Cancer Center at North Colorado Medical Center Greeley Colorado 80631 —
Associated Neurologists of Southern CT, P.C. Fairfield Connecticut 06824 —
Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C. District of Columbia 20010 —
GenesisCare USA Jacksonville Florida 32204 —
Miami Cancer Institute Miami Florida 33176 —
Mount Sinai Medical Center Miami Beach Florida 33140 —
AdventHealth Orlando Orlando Florida 32804 —
Adult Oncology Research Orlando Florida 32806 —
BRCR Medical Center INC Plantation Florida — —
University of Illinois Cancer Center Chicago Illinois 60612 —
Illinois CancerCare, P.C. Peoria Illinois 61615 —
Southern Illinois University, School of Medicine, Simmons Cancer Institute at SIU Springfield Illinois 62702 —
Franciscan Health Indianapolis Indianapolis Indiana 46237 —
University of Kansas Cancer Center Westwood Kansas 66205 —
Norton Cancer Institute Louisville Kentucky 40202 —
University Medical Center, Inc; DBA University of Louisville Louisville Kentucky 40202 —
LSU Health Sciences Center -New Orleans New Orleans Louisiana 70112 —
Tulane Cancer Center New Orleans Louisiana 70112 —
CHRISTUS Health Shreveport Louisiana 71105 —
Central Maine Medical Center Lewiston Maine — —
University of Maryland School of Medicine Baltimore Maryland 21201 —
Tufts Medical Center, Division of Hematology and Oncology Boston Massachusetts 02111 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Clinical Oncology Associates Farmington Hills Michigan 48336 —
Detroit Clinical Research Center Farmington Hills Michigan 48336 —
Saint Joseph Mercy Health System Ypsilanti Michigan 48197 —
HealthPartners Institute, Regions Cancer Care Center Saint Paul Minnesota 55101 —
Saint Luke's Cancer Institute Kansas City Missouri 64111 —
Washington University School of Medicine St Louis Missouri 63110 —
CHI Health Research Center Omaha Nebraska 68124 —
Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha Nebraska 68130 —
University of Nebraska Medical Center Omaha Nebraska — —
OptumCare Cancer Care Las Vegas Nevada 89102 —
Renown Regional Medical Center Institute for Cancer Reno Nevada 89502 —
Presbyterian Cancer Center Albuquerque New Mexico 87110 —
New York-Presbyterian/Queens Radiation Oncology Flushing New York 11355 —
Northern Westchester Hospital Mount Kisco New York 10549-3417 —
Stony Brook Cancer Center Stony Brook New York 11794 —
Oncology Specialists of Charlotte Charlotte North Carolina 28204 —
W.G. Bill Hefner VA Med Center Salisbury North Carolina 28144 —
Piedmont Radiation Oncology, PA Winston-Salem North Carolina 27103 —
Summa Health Akron Ohio 44304 —
Toledo Clinic Cancer Center Toledo Ohio 43623 —
Vita Medical Associates, P.C. Bethlehem Pennsylvania 18015 —
Geisinger Cancer Institute Danville Pennsylvania 17822 —
UT/Erlanger Oncology & Hematology Chattanooga Tennessee 37403 —
Texas Oncology - Amarillo Amarillo Texas 79106 —
Texas Oncology - Arlington Arlington Texas 76012 —
Christus Health Spohn Ministry Corpus Christi Texas 78404 —
Dallas VA Medical Center Dallas Texas 75216 —
Texas Oncology- Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
The University of Texas Southwestern Medical Center Dallas Texas 75390 —
Oncology Consultants, P.A. Houston Texas 77030 —
Texas Oncology-McKinney McKinney Texas 75071 —
Texas Oncology - Paris Paris Texas 75460 —
Texas Oncology- Plano West Plano Texas 75093 —
Baylor Scott & White Health/McClinton Cancer Center Waco Texas 76712 —
Texas Oncology-Waco Waco Texas 76712 —
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 —
Overlake Medical Center & Clinics Bellevue Washington 98004 —
UW Carbone Cancer Center Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02973789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02973789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →